Avience Biomedicals Limited (NSE: AVIENCE) is a New Delhi, Delhi-based company in the Medical Testing, Analyzing, and Diagnostic Equipment industry. With a market capitalisation of ₹144 Cr, it ranks #2,937 by market cap among the 6,197 Indian listed companies on FinBizNet, and #7 of 7 in Medical Testing, Analyzing, and Diagnostic Equipment. The share price was ₹253.35 as of 19 Nov 2026.
| Current Price | ₹253.35 |
|---|---|
| Market Cap | ₹144 Cr |
| NSE Symbol | AVIENCE |
| Sector | Health Care > Health Care Equipment and Services > Health Care Equipment and Supplies |
| Sub-Industry | Health Care Equipment > Medical Testing, Analyzing, and Diagnostic Equipment |
| P/E Ratio | 11.7 |
| Return on Equity | 27.86% |
| Return on Assets | 13.24% |
| Beta (1Y) | 1.5 |
| Headquarters | New Delhi, Delhi |
| Website | avienbio.com |
Avience Biomedicals Limited manufactures and sells Vitro-Diagnostic products and medical devices in India. The company's products include reagents and consumables, such as biochemistry reagents, hematology reagents, immunoassay reagents, electrolyte reagents, and cuvettes, pipette tips, test tubes, microplates, and filters; diagnostic instruments and equipment includes automated biochemistry analysers, hematology analysers, immunoassay analysers, molecular diagnostic instruments, microbiology instruments and electrolyte analyser; rapid test kits; molecular test; covid detection kits; petri dishes; other lab equipment; cleaning solutions; oxygen concentrators; culture media; and plastic ware products. In addition, it offers substances used in laboratories to support the growth and multiplication of microorganisms, such as bacteria, fungi, and viruses, and distributes branded equipment. The company also offers post-sales support that includes annual and comprehensive maintenance contract
1. Diagnostic Kits / Equipment-This segment offers rapid test kits. 2. NA-NA 3. NA-NA 4. NA-NA
1. Diagnostic Kits / Equipment-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Molbio Diagnostics Limited | ₹15,196 Cr | 94.7 | — | ₹259 Cr | — |
| Hemant Surgical Industries Lim | ₹939 Cr | 43.4 | — | — | +102.0% |
| Credent Connect N Care | ₹792 Cr | 31 | — | — | — |
| QMS Medical Allied Services Limited | ₹330 Cr | 32.4 | 12.29% | ₹53 Cr | +80.0% |
| Nureca Ltd | ₹290 Cr | 143.7 | 1.11% | ₹59 Cr | +11.3% |
| Earkart Limited | ₹151 Cr | 27.6 | — | ₹0 Cr | -54.3% |
| Avience Biomedicals Limited | ₹144 Cr | 11.7 | 27.86% | — | — |
Listed by market capitalisation. Ratios are shown for context only.
Avience Biomedicals Limited is trading at ₹253.35, with a market capitalisation of ₹144 Cr.
Avience Biomedicals Limited operates in the Health Care > Health Care Equipment and Services > Health Care Equipment and Supplies space (Health Care Equipment > Medical Testing, Analyzing, and Diagnostic Equipment).
Avience Biomedicals Limited has a P/E of 11.7 and a return on equity of 27.86%.
Avience Biomedicals Limited is listed on the NSE under the symbol AVIENCE.
Data as of 19 Nov 2026. Descriptive market data only — not investment advice.